STOCK TITAN

[S-8 POS] Amedisys Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
S-8 POS
Rhea-AI Filing Summary

Amedisys, Inc. submitted a post-effective amendment to deregister any and all shares of its common stock that remain registered but unsold or otherwise unissued under multiple previously filed S-8 registration statements. The filing lists the specific S-8 files and original share amounts for plans including employee stock purchase and omnibus incentive plans.

The notice clarifies that the listed share counts do not account for interim corporate actions such as stock splits.

Amedisys, Inc. ha presentato un emendamento post-effective per cancellare la registrazione di tutte le azioni ordinarie rimaste registrate ma non vendute o comunque non emesse ai sensi di più precedenti moduli S-8. La documentazione elenca i singoli file S-8 e gli importi originali di azioni relativi a piani quali il piano di acquisto azioni per dipendenti e il piano di incentivi omnibus.

La comunicazione precisa che i conteggi delle azioni indicati non tengono conto di azioni societarie intervenute nel frattempo, come frazionamenti azionari.

Amedisys, Inc. presentó una enmienda post‑efectiva para cancelar la registración de todas las acciones ordinarias que permanecen registradas pero no vendidas o no emitidas bajo múltiples declaraciones de registro S-8 ya presentadas. La presentación detalla los expedientes S-8 específicos y las cantidades originales de acciones correspondientes a planes, incluidos el plan de compra de acciones para empleados y el plan de incentivos omnibus.

El aviso aclara que los recuentos de acciones listados no consideran acciones corporativas interinas, como los desdoblamientos de acciones.

Amedisys, Inc.는 다수의 기존 S-8 등록신고서에 따라 현재 등록되어 있으나 미판매 또는 미발행 상태인 보통주 전부의 등록을 말소하기 위한 사후 효력 수정서(post-effective amendment)를 제출했습니다. 제출서류에는 직원 주식매수 계획 및 종합 인센티브 계획을 포함한 각 S-8 파일과 원래 발행 주식 수가 명시되어 있습니다.

해당 공지는 기재된 주식 수가 주식 분할과 같은 중간 기업 행위를 반영하지 않는다고 명확히 밝힙니다.

Amedisys, Inc. a déposé un amendement post‑effectif visant à radier l’enregistrement de toutes les actions ordinaires qui restent enregistrées mais non vendues ou non émises au titre de plusieurs déclarations d’enregistrement S‑8 antérieures. le dossier énumère les S‑8 concernés et les nombres d’actions initiaux destinés aux plans, y compris le plan d’achat d’actions pour les employés et le plan d’incitation omnibus.

L’avis précise que les décomptes d’actions indiqués ne tiennent pas compte d’opérations d’entreprise intervenues entre‑temps, telles que des divisions d’actions.

Amedisys, Inc. hat einen post‑effectiven Änderungsantrag eingereicht, um die Registrierung sämtlicher Stammaktien, die zwar weiterhin registriert, aber nicht verkauft bzw. anderweitig nicht ausgegeben wurden, aus mehreren zuvor eingereichten S‑8‑Registrierungsformularen zu streichen. Die Einreichung listet die einzelnen S‑8‑Akten und die ursprünglich vorgesehenen Aktienmengen für Pläne wie den Mitarbeiteraktienkaufplan und den Omnibus‑Anreizplan auf.

Die Mitteilung macht deutlich, dass die aufgeführten Aktienzahlen Zwischenereignisse der Gesellschaft, wie etwa Aktiensplits, nicht berücksichtigen.

Positive
  • Deregistration of unsold or unissued shares under multiple S-8s is explicitly executed, clarifying the company's registered share status
  • Detailed list of affected registration statements and original share amounts is provided for transparency
Negative
  • None.

Insights

TL;DR: Administrative deregistration of unsold S-8 shares reduces registered-but-unissued capacity; no financial metrics disclosed.

The filing is procedural: Amedisys is removing from registration any remaining unsold or unissued shares under several historical S-8s. This does not report issuances, repurchases, or changes to outstanding share count, and it provides no earnings, cash flow, or liability information. For investors, the item is non-operational and does not, by itself, indicate dilution or capital changes.

TL;DR: Routine corporate housekeeping to clean up expired or unused employee plan registrations; not material to governance.

The document enumerates prior S-8 registration statements and specifies that any registered but unsold or unissued shares under those filings are being deregistered. It also notes that share counts shown exclude interim corporate actions. This is a standard post-effective amendment reflecting administrative maintenance of the company’s SEC filings rather than a governance change.

Amedisys, Inc. ha presentato un emendamento post-effective per cancellare la registrazione di tutte le azioni ordinarie rimaste registrate ma non vendute o comunque non emesse ai sensi di più precedenti moduli S-8. La documentazione elenca i singoli file S-8 e gli importi originali di azioni relativi a piani quali il piano di acquisto azioni per dipendenti e il piano di incentivi omnibus.

La comunicazione precisa che i conteggi delle azioni indicati non tengono conto di azioni societarie intervenute nel frattempo, come frazionamenti azionari.

Amedisys, Inc. presentó una enmienda post‑efectiva para cancelar la registración de todas las acciones ordinarias que permanecen registradas pero no vendidas o no emitidas bajo múltiples declaraciones de registro S-8 ya presentadas. La presentación detalla los expedientes S-8 específicos y las cantidades originales de acciones correspondientes a planes, incluidos el plan de compra de acciones para empleados y el plan de incentivos omnibus.

El aviso aclara que los recuentos de acciones listados no consideran acciones corporativas interinas, como los desdoblamientos de acciones.

Amedisys, Inc.는 다수의 기존 S-8 등록신고서에 따라 현재 등록되어 있으나 미판매 또는 미발행 상태인 보통주 전부의 등록을 말소하기 위한 사후 효력 수정서(post-effective amendment)를 제출했습니다. 제출서류에는 직원 주식매수 계획 및 종합 인센티브 계획을 포함한 각 S-8 파일과 원래 발행 주식 수가 명시되어 있습니다.

해당 공지는 기재된 주식 수가 주식 분할과 같은 중간 기업 행위를 반영하지 않는다고 명확히 밝힙니다.

Amedisys, Inc. a déposé un amendement post‑effectif visant à radier l’enregistrement de toutes les actions ordinaires qui restent enregistrées mais non vendues ou non émises au titre de plusieurs déclarations d’enregistrement S‑8 antérieures. le dossier énumère les S‑8 concernés et les nombres d’actions initiaux destinés aux plans, y compris le plan d’achat d’actions pour les employés et le plan d’incitation omnibus.

L’avis précise que les décomptes d’actions indiqués ne tiennent pas compte d’opérations d’entreprise intervenues entre‑temps, telles que des divisions d’actions.

Amedisys, Inc. hat einen post‑effectiven Änderungsantrag eingereicht, um die Registrierung sämtlicher Stammaktien, die zwar weiterhin registriert, aber nicht verkauft bzw. anderweitig nicht ausgegeben wurden, aus mehreren zuvor eingereichten S‑8‑Registrierungsformularen zu streichen. Die Einreichung listet die einzelnen S‑8‑Akten und die ursprünglich vorgesehenen Aktienmengen für Pläne wie den Mitarbeiteraktienkaufplan und den Omnibus‑Anreizplan auf.

Die Mitteilung macht deutlich, dass die aufgeführten Aktienzahlen Zwischenereignisse der Gesellschaft, wie etwa Aktiensplits, nicht berücksichtigen.

As filed with the Securities and Exchange Commission on August 14, 2025

Registration Statement File No. 333-60525 

Registration Statement File No. 333-51704 

Registration Statement File No. 333-53786 

Registration Statement File No. 333-143967

Registration Statement File No. 333-152359

Registration Statement File No. 333-182347

Registration Statement File No. 333-205267

Registration Statement File No. 333-225461

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

Post-Effective Amendment No. 1 to Form S-8 Registration Statement (No. 333-60525)

Post-Effective Amendment No. 1 to Form S-8 Registration Statement (No. 333-51704)

Post-Effective Amendment No. 1 to Form S-8 Registration Statement (No. 333-53786)

Post-Effective Amendment No. 1 to Form S-8 Registration Statement (No. 333-143967)

Post-Effective Amendment No. 1 to Form S-8 Registration Statement (No. 333-152359)

Post-Effective Amendment No. 1 to Form S-8 Registration Statement (No. 333-182347)

Post-Effective Amendment No. 1 to Form S-8 Registration Statement (No. 333-205267)

Post-Effective Amendment No. 1 to Form S-8 Registration Statement (No. 333-225461)

UNDER

THE SECURITIES ACT OF 1933

 

 

Amedisys, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware    11-3131700

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

3854 American Way, Suite A, Baton Rouge, LA    70816
(Address of Principal Executive Offices)    (Zip Code)

Employee Stock Purchase Plan

Amedisys, Inc. 1998 Stock Option Plan

Amedisys, Inc. Directors’ Stock Option Plan

Amedisys, Inc. Employee Stock Purchase Plan

Amedisys, Inc. 2008 Omnibus Incentive Compensation Plan

Amedisys, Inc. 2018 Omnibus Incentive Compensation Plan

(Full title of the plan)

Scott G. Ginn

Chief Financial Officer

3854 American Way, Suite A

Baton Rouge, LA 70816

(Name and address of agent for service)

(225) 292-2031 or (800) 467-2662

(Telephone number, including area code, of agent for service)

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller reporting company  
     Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

 
 


EXPLANATORY NOTE

DEREGISTRATION OF SECURITIES

Amedisys, Inc., a Delaware corporation (the “Company”), is filing these Post-Effective Amendments (these “Post-Effective Amendments”) to the following Registration Statements on Form S-8 (collectively, the “Registration Statements”) previously filed by the Company with the U.S. Securities and Exchange Commission (the “Commission”), to deregister any and all shares of the Company’s common stock, par value $0.001 per share (the “Company Common Stock”), registered but unsold or otherwise unissued under each such Registration Statement as of the date hereof (note that the share numbers listed below do not take into account corporate actions, such as stock splits, taken in the interim):

 

   

Registration Statement on Form S-8 (Registration File No. 333-60525), which was filed with the Commission on August 3, 1998, pertaining to the registration of 1,000,000 shares of Company Common Stock under the Employee Stock Purchase Plan;

 

   

Registration Statement on Form S-8 (Registration File No. 333-51704), which was filed with the Commission on December 12, 2000, pertaining to the registration of 1,425,000 shares of Company Common Stock under the Company’s 1998 Stock Option Plan;

 

   

Registration Statement on Form S-8 (Registration File No. 333-53786), which was filed with the Commission on January 16, 2001, pertaining to the registration of 75,000 shares of Company Common Stock under the Company’s Directors’ Stock Option Plan;

 

   

Registration Statement on Form S-8 (Registration File No. 333-143967), which was filed with the Commission on June 22, 2007, pertaining to the registration of 2,500,000 shares of Company Common Stock under the Company’s 1998 Stock Option Plan and Employee Stock Purchase Plan;

 

   

Registration Statement on Form S-8 (Registration File No. 333-152359), which was filed with the Commission on July 16, 2008, pertaining to the registration of 1,862,459 shares of Company Common Stock under the Company’s 2008 Omnibus Incentive Compensation Plan;

 

   

Registration Statement on Form S-8 (Registration File No. 333-182347), which was filed with the Commission on June 26, 2012, pertaining to the registration of 4,100,000 shares of Company Common Stock under the Company’s 2008 Omnibus Incentive Compensation Plan and Employee Stock Purchase Plan;

 

   

Registration Statement on Form S-8 (Registration File No. 333-205267), which was filed with the Commission on June 26, 2015, pertaining to the registration of 1,500,000 shares of Company Common Stock under the Company’s 2008 Omnibus Incentive Compensation Plan; and

 

   

Registration Statement on Form S-8 (Registration File No. 333-225461), which was filed with the Commission on June 6, 2018, pertaining to the registration of 2,500,000 shares of Company Common Stock under the Company’s 2018 Omnibus Incentive Compensation Plan.

On June 26, 2023, the Company entered into that certain Agreement and Plan of Merger with UnitedHealth Group Incorporated, a Delaware corporation (“UnitedHealth Group”) and Aurora Holdings Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of UnitedHealth Group (“Merger Sub”), which provides for the merger of Merger Sub with and into the Company, with the Company surviving as a wholly owned subsidiary of UnitedHealth Group (the “Merger”). The Merger became effective on August 14, 2025, pursuant to a Certificate of Merger filed with the Secretary of State of the State of Delaware.

In connection with the Merger, the Company has terminated any and all of the offerings of the Company’s securities pursuant to the Registration Statements. In accordance with the undertakings made by the Company in the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities registered under the Registration Statements that remain unsold or otherwise unissued at the termination of the offerings, the Company hereby amends the Registration Statements and removes from registration any and all of the securities of the Company registered under the Registration Statements that remain unsold or otherwise unissued as of the date of these Post-Effective Amendments, and hereby terminates the effectiveness of each of the Registration Statements.


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Baton Rouge, State of Louisiana, on the 14th day of August, 2025.

 

AMEDISYS, INC.,
By:   /s/ Richard Ashworth
Name:   Richard Ashworth
Title:   President and Chief Executive Officer

 

Note:

Pursuant to Rule 478 under the Securities Act of 1933, as amended, no other person is required to sign these Post-Effective Amendments to the Registration Statements.

FAQ

What did the Amedisys (AMED) filing do?

The company filed a post-effective amendment to deregister any registered but unsold or unissued common stock under several prior S-8 registration statements.

Which S-8 registration statements are affected for AMED?

The filing lists multiple S-8s including Nos. 333-60525, 333-51704, 333-53786, 333-143967, 333-152359, 333-182347, 333-205267, and 333-225461.

Does the filing state how many shares are being deregistered now?

The document provides the original registered share amounts per S-8 but notes those counts do not account for interim corporate actions and does not state current deregistered totals.

Does this filing change Amedisys's outstanding share count or report issuances?

No. The filing is administrative and does not disclose any new issuances, repurchases, or changes to the outstanding share count.
Amedisys Inc

NASDAQ:AMED

AMED Rankings

AMED Latest News

AMED Latest SEC Filings

AMED Stock Data

3.32B
32.24M
1.95%
96.37%
9.73%
Medical Care Facilities
Services-home Health Care Services
Link
United States
BATON ROUGE